Hallucination-free generative AI for FDA regulatory documents

FDA submissions are required from the earliest stages of developing therapeutics, diagnostics, and devices – and they can demand hundreds of thousands of dollars, six months, and teams of experienced writers. Joel Shor from Nomos AI is building hallucination-free generative AI that helps junior scientists produce better regulatory documents at a fraction of the cost and time.

Biography

What if a junior scientist could draft an FDA submission in a tenth of the time? Joel Shor is an AI-and-biotech researcher and founder of Move37 Labs. He spent roughly a decade leading machine-learning teams at Google — where he founded the Audio Biomarkers team behind Project Euphonia — and at Alphabet’s Verily, and served as Head of ML at Deep Genomics; he is now building hallucination-free generative AI for regulatory documents.